Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients.
van de Sand L, Braß P, Gregorius J, Pattberg K, Engler A, Dittmer U, Taube C, Brock S, Berger MM, Brenner T, Witzke O, Krawczyk A. van de Sand L, et al. Among authors: witzke o. J Clin Med. 2022 Dec 29;12(1):283. doi: 10.3390/jcm12010283. J Clin Med. 2022. PMID: 36615083 Free PMC article.
Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNA.
Wolff N, Kollenda S, Klein K, Loza K, Heggen M, Brochhagen L, Witzke O, Krawczyk A, Hilger I, Epple M. Wolff N, et al. Among authors: witzke o. Nanoscale Adv. 2022 Sep 5;4(21):4502-4516. doi: 10.1039/d2na00250g. eCollection 2022 Oct 25. Nanoscale Adv. 2022. PMID: 36341304 Free PMC article.
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination.
Paniskaki K, Konik MJ, Anft M, Meister TL, Marheinecke C, Pfaender S, Jäger J, Krawczyk A, Zettler M, Dolff S, Westhoff TH, Rohn H, Stervbo U, Witzke O, Babel N. Paniskaki K, et al. Among authors: witzke o. Front Immunol. 2022 Oct 31;13:1031254. doi: 10.3389/fimmu.2022.1031254. eCollection 2022. Front Immunol. 2022. PMID: 36389833 Free PMC article.
Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State.
Limmer A, Engler A, Kattner S, Gregorius J, Pattberg KT, Schulz R, Schwab J, Roth J, Vogl T, Krawczyk A, Witzke O, Zelinskyy G, Dittmer U, Brenner T, Berger MM. Limmer A, et al. Among authors: witzke o. Vaccines (Basel). 2023 Feb 13;11(2):435. doi: 10.3390/vaccines11020435. Vaccines (Basel). 2023. PMID: 36851312 Free PMC article.
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.
Alt M, Wolf S, van de Sand L, Dittrich R, Tertel T, Brochhagen L, Dirks M, Aufderhorst UW, Thümmler L, Otte M, Rainer K, Dittmer U, Giebel B, Trilling M, Silke Heilingloh C, Lotfi R, Roggendorf M, Witzke O, Krawczyk A. Alt M, et al. Among authors: witzke o. Front Immunol. 2023 Mar 16;14:1143870. doi: 10.3389/fimmu.2023.1143870. eCollection 2023. Front Immunol. 2023. PMID: 37006290 Free PMC article.
Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19.
Paniskaki K, Konik MJ, Anft M, Heidecke H, Meister TL, Pfaender S, Krawczyk A, Zettler M, Jäger J, Gaeckler A, Dolff S, Westhoff TH, Rohn H, Stervbo U, Scheibenbogen C, Witzke O, Babel N. Paniskaki K, et al. Among authors: witzke o. Front Microbiol. 2023 Jun 2;14:1196721. doi: 10.3389/fmicb.2023.1196721. eCollection 2023. Front Microbiol. 2023. PMID: 37333646 Free PMC article.
Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019.
Doevelaar AAN, Bachmann M, Hölzer B, Seibert FS, Rohn BJ, Zgoura P, Witzke O, Dittmer U, Brenner T, Paniskaki K, Yilmaz S, Dittmer R, Schneppenheim S, Wilhelm J, Stervbo U, Babel N, Budde U, Westhoff TH. Doevelaar AAN, et al. Among authors: witzke o. Sci Rep. 2023 Jun 28;13(1):10501. doi: 10.1038/s41598-023-37405-5. Sci Rep. 2023. PMID: 37380654 Free PMC article.
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
Bormann M, Brochhagen L, Alt M, Otte M, Thümmler L, van de Sand L, Kraiselburd I, Thomas A, Gosch J, Braß P, Ciesek S, Widera M, Dolff S, Dittmer U, Witzke O, Meyer F, Lindemann M, Schönfeld A, Rohn H, Krawczyk A. Bormann M, et al. Among authors: witzke o. Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023. Front Immunol. 2023. PMID: 37520539 Free PMC article.
Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients.
Westmeier J, Brochtrup A, Paniskaki K, Karakoese Z, Werner T, Sutter K, Dolff S, Limmer A, Mittermüller D, Liu J, Zheng X, Koval T, Kaidashev I, Berger MM, Herbstreit F, Brenner T, Witzke O, Trilling M, Lu M, Yang D, Babel N, Westhoff T, Dittmer U, Zelinskyy G. Westmeier J, et al. Among authors: witzke o. Front Immunol. 2023 Oct 25;14:1236374. doi: 10.3389/fimmu.2023.1236374. eCollection 2023. Front Immunol. 2023. PMID: 37946732 Free PMC article.
378 results